Industry: Off-Label Rules Mustn’t Rule Out Public Forum Discussions
The FDA should revise draft off-label guidance to ensure devicemakers can respond immediately to unsolicited questions on off-label uses posed in public forums, industry maintains.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.